2020 Q3 Form 10-Q Financial Statement

#000143774920023210 Filed on November 09, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2019 Q3 2019 Q2
Revenue $39.13M $46.12M $47.77M
YoY Change -15.15% 13.66% 12.27%
Cost Of Revenue $17.39M $19.88M $21.94M
YoY Change -12.56% 6.4% 8.76%
Gross Profit $21.75M $26.23M $25.83M
YoY Change -17.1% 19.87% 15.44%
Gross Profit Margin 55.57% 56.88% 54.07%
Selling, General & Admin $19.53M $25.00M $22.26M
YoY Change -21.9% 27.29% 8.92%
% of Gross Profit 89.79% 95.3% 86.17%
Research & Development $3.432M $3.643M $3.273M
YoY Change -5.79% 12.3% -20.07%
% of Gross Profit 15.78% 13.89% 12.67%
Depreciation & Amortization $340.0K $360.0K $410.0K
YoY Change -5.56% 16.13% 41.38%
% of Gross Profit 1.56% 1.37% 1.59%
Operating Expenses $22.96M $28.64M $25.53M
YoY Change -19.85% 25.17% 4.08%
Operating Profit -$1.211M -$2.409M $299.0K
YoY Change -49.73% 141.38% -113.87%
Interest Expense -$380.0K -$150.0K $50.00K
YoY Change 153.33% 200.0% -138.46%
% of Operating Profit 16.72%
Other Income/Expense, Net -$382.0K -$146.0K $46.00K
YoY Change 161.64% 197.96% -135.66%
Pretax Income -$1.593M -$2.555M $345.0K
YoY Change -37.65% 144.03% -115.11%
Income Tax $700.0K $73.00K -$243.0K
% Of Pretax Income -70.43%
Net Earnings -$2.257M -$2.628M $588.0K
YoY Change -14.12% 201.03% -137.4%
Net Earnings / Revenue -5.77% -5.7% 1.23%
Basic Earnings Per Share -$0.13 -$0.19 $0.04
Diluted Earnings Per Share -$0.13 -$0.19 $0.04
COMMON SHARES
Basic Shares Outstanding 17.60M shares 14.18M 14.09M
Diluted Shares Outstanding 17.60M shares 14.18M 14.36M

Balance Sheet

Concept 2020 Q3 2019 Q3 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $42.40M $29.30M $31.70M
YoY Change 44.71% 8.92% 9.31%
Cash & Equivalents $29.39M $22.88M $27.67M
Short-Term Investments $13.00M $6.400M $4.000M
Other Short-Term Assets $6.900M $5.300M $4.500M
YoY Change 30.19% 43.24% 28.57%
Inventory $29.33M $34.04M $26.89M
Prepaid Expenses
Receivables $17.60M $23.22M $24.92M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $96.26M $91.93M $88.01M
YoY Change 4.72% 5.22% 3.87%
LONG-TERM ASSETS
Property, Plant & Equipment $2.391M $2.771M $2.834M
YoY Change -13.71% -0.47% 7.67%
Goodwill $1.339M $1.339M $1.339M
YoY Change 0.0% 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $5.290M $6.410M $6.311M
YoY Change -17.47% 5.99% 8.68%
Total Long-Term Assets $27.17M $19.31M $19.93M
YoY Change 40.67% -38.84% -35.7%
TOTAL ASSETS
Total Short-Term Assets $96.26M $91.93M $88.01M
Total Long-Term Assets $27.17M $19.31M $19.93M
Total Assets $123.4M $111.2M $107.9M
YoY Change 10.96% -6.48% -6.73%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.799M $14.14M $11.44M
YoY Change -51.92% 6.15% 6.5%
Accrued Expenses $25.64M $28.10M $27.03M
YoY Change -8.73% 22.67% 18.76%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $400.0K $600.0K $600.0K
YoY Change -33.33%
Total Short-Term Liabilities $45.13M $55.27M $52.86M
YoY Change -18.34% 22.37% 23.54%
LONG-TERM LIABILITIES
Long-Term Debt $7.500M $700.0K $800.0K
YoY Change 971.43%
Other Long-Term Liabilities $292.0K $690.0K $782.0K
YoY Change -57.68% 7.81% 17.59%
Total Long-Term Liabilities $292.0K $690.0K $782.0K
YoY Change -57.68% 7.81% 17.59%
TOTAL LIABILITIES
Total Short-Term Liabilities $45.13M $55.27M $52.86M
Total Long-Term Liabilities $292.0K $690.0K $782.0K
Total Liabilities $71.42M $67.25M $64.76M
YoY Change 6.21% 38.55% 39.71%
SHAREHOLDERS EQUITY
Retained Earnings -$62.42M -$34.27M -$31.64M
YoY Change 82.15% -1601.1% -1102.6%
Common Stock $114.4M $78.32M $74.88M
YoY Change 46.11% 14.85% 12.94%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $52.01M $43.99M $43.18M
YoY Change
Total Liabilities & Shareholders Equity $123.4M $111.2M $107.9M
YoY Change 10.96% -6.48% -6.73%

Cashflow Statement

Concept 2020 Q3 2019 Q3 2019 Q2
OPERATING ACTIVITIES
Net Income -$2.257M -$2.628M $588.0K
YoY Change -14.12% 201.03% -137.4%
Depreciation, Depletion And Amortization $340.0K $360.0K $410.0K
YoY Change -5.56% 16.13% 41.38%
Cash From Operating Activities -$3.450M -$2.270M $4.030M
YoY Change 51.98% 40.12% 13.52%
INVESTING ACTIVITIES
Capital Expenditures -$330.0K -$200.0K -$250.0K
YoY Change 65.0% -68.25% -47.92%
Acquisitions
YoY Change
Other Investing Activities -$140.0K -$2.410M $3.990M
YoY Change -94.19% -143.35% 57.09%
Cash From Investing Activities -$490.0K -$2.610M $3.730M
YoY Change -81.23% -153.05% 81.07%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -330.0K 100.0K 740.0K
YoY Change -430.0% -23.08% -61.46%
NET CHANGE
Cash From Operating Activities -3.450M -2.270M 4.030M
Cash From Investing Activities -490.0K -2.610M 3.730M
Cash From Financing Activities -330.0K 100.0K 740.0K
Net Change In Cash -4.270M -4.780M 8.500M
YoY Change -10.67% -239.36% 12.88%
FREE CASH FLOW
Cash From Operating Activities -$3.450M -$2.270M $4.030M
Capital Expenditures -$330.0K -$200.0K -$250.0K
Free Cash Flow -$3.120M -$2.070M $4.280M
YoY Change 50.72% 109.09% 6.2%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
700000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1200000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
73000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-55000 USD
CY2020Q3 cutr Lease Rightofuse Asset
LeaseRightofuseAsset
18208000 USD
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
18105000 USD
CY2020Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
407000 USD
CY2020Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
292000 USD
CY2020Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
699000 USD
CY2020Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
121000 USD
CY2020Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
14000 USD
CY2019Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1361000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1121000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1226000
CY2020Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
752000 USD
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
545000 USD
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
49000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
2208000 USD
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
49000 USD
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
513000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
1987000 USD
CY2020Q3 us-gaap Litigation Reserve
LitigationReserve
0 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 pure
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
39132000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
46117000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
97740000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
129917000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
39132000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
46117000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
97740000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
129917000 USD
CY2020Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y
CY2020Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y6M
CY2020Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.047 pure
CY2020Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.056 pure
CY2020Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
160000 USD
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
160000 USD
CY2020Q3 us-gaap Lessor Operating Lease Payments To Be Received Next Rolling Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextRollingTwelveMonths
1039000 USD
CY2020Q3 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
1039000 USD
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
17632649
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1505000 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1354000 USD
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17625849
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17625849
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14315586
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14315586
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7702000 USD
CY2020Q3 us-gaap Goodwill
Goodwill
1339000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
1339000 USD
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5290000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6411000 USD
CY2020Q3 us-gaap Assets
Assets
123427000 USD
CY2020Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
500000 USD
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
423000 USD
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
17645000 USD
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-146000 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
2303000 USD
CY2020Q3 us-gaap Lessor Operating Lease Term Of Contract
LessorOperatingLeaseTermOfContract
P3Y
cutr Lessor Operating Lease Initial Term Of Contract
LessorOperatingLeaseInitialTermOfContract
P12M
CY2020Q3 cutr Accounts Receivable Provision For Loss Reversal
AccountsReceivableProvisionForLossReversal
53000000000 USD
CY2019Q4 cutr Debt Securities Availableforsale Net Accumulated Gross Unrealized Gain Loss Before Tax
DebtSecuritiesAvailableforsaleNetAccumulatedGrossUnrealizedGainLossBeforeTax
0 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
60000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-2257000 USD
CY2020Q3 us-gaap Lessor Operating Lease Term Of Contract
LessorOperatingLeaseTermOfContract
P3Y
cutr Lessor Operating Lease Initial Term Of Contract
LessorOperatingLeaseInitialTermOfContract
P12M
CY2019Q4 us-gaap Litigation Reserve
LitigationReserve
0 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
29394000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26316000 USD
CY2020Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
13046000 USD
CY2019Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
7605000 USD
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
17597000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
21556000 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
29333000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
33921000 USD
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6892000 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5648000 USD
CY2020Q3 us-gaap Assets Current
AssetsCurrent
96262000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
95046000 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2391000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2817000 USD
CY2019Q4 us-gaap Assets
Assets
113738000 USD
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
6799000 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
12685000 USD
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
25644000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
30307000 USD
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1608000 USD
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2800000 USD
CY2020Q3 us-gaap Extended Product Warranty Accrual Current
ExtendedProductWarrantyAccrualCurrent
1497000 USD
CY2019Q4 us-gaap Extended Product Warranty Accrual Current
ExtendedProductWarrantyAccrualCurrent
1999000 USD
CY2020Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
9580000 USD
CY2019Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
10831000 USD
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
45128000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
58622000 USD
CY2020Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
2244000 USD
CY2019Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
3391000 USD
CY2020Q3 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
93000 USD
CY2019Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
93000 USD
CY2020Q3 us-gaap Long Term Debt
LongTermDebt
7167000 USD
CY2019Q4 us-gaap Long Term Debt
LongTermDebt
0 USD
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
16497000 USD
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5112000 USD
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
292000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
578000 USD
CY2020Q3 us-gaap Liabilities
Liabilities
71421000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
67796000 USD
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
18000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
14000 USD
CY2020Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
114410000 USD
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
82346000 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-62423000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-36358000 USD
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-60000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
52006000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
45942000 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
123427000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
113738000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
39132000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
46117000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
97740000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
129917000 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
17386000 USD
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
19884000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
50034000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
60544000 USD
CY2020Q3 us-gaap Gross Profit
GrossProfit
21746000 USD
CY2019Q3 us-gaap Gross Profit
GrossProfit
26233000 USD
us-gaap Gross Profit
GrossProfit
47706000 USD
us-gaap Gross Profit
GrossProfit
69373000 USD
CY2020Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
12286000 USD
CY2019Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
17691000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
38109000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
50786000 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3432000 USD
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3643000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10294000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10622000 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7239000 USD
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7308000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
23575000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18100000 USD
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
22957000 USD
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
28642000 USD
us-gaap Operating Expenses
OperatingExpenses
71978000 USD
us-gaap Operating Expenses
OperatingExpenses
79508000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1211000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2409000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-24272000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-10135000 USD
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-382000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-586000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-180000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1593000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-2555000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-24858000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-10315000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
664000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
73000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1207000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-55000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-2257000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-2628000 USD
us-gaap Net Income Loss
NetIncomeLoss
-26065000 USD
us-gaap Net Income Loss
NetIncomeLoss
-10260000 USD
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.13
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.19
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.59
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.73
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
17603000
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
14182000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
16368000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
14095000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-2257000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-2628000 USD
us-gaap Net Income Loss
NetIncomeLoss
-26065000 USD
us-gaap Net Income Loss
NetIncomeLoss
-10260000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax
-2000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
45942000 USD
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
437000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
419000 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
26495000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax
1000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax
-2000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax
10000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
-0 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
-0 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
-63000 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
-0 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
-2000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
1000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
61000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
10000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-2000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
61000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
10000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2259000 USD
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2627000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-26004000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10250000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
52499000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
8000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-224000 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1982000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-2257000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-2000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
52006000 USD
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-3340000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8057000 USD
us-gaap Net Income Loss
NetIncomeLoss
-26065000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
61000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
52006000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
43182000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
437000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-180000 USD
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3178000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-2628000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
43990000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
46386000 USD
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
833000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
767000 USD
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-750000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7004000 USD
us-gaap Net Income Loss
NetIncomeLoss
-10260000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
10000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
43990000 USD
us-gaap Net Income Loss
NetIncomeLoss
-26065000 USD
us-gaap Net Income Loss
NetIncomeLoss
-10260000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
8057000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
7004000 USD
us-gaap Depreciation
Depreciation
1056000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1750000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
2017000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
2169000 USD
us-gaap Capitalized Computer Software Impairments1
CapitalizedComputerSoftwareImpairments1
805000 USD
us-gaap Capitalized Computer Software Impairments1
CapitalizedComputerSoftwareImpairments1
USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-77000 USD
us-gaap Depreciation
Depreciation
1184000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
647000 USD
cutr Change In Rightofuse Asset And Liability Due To Modification
ChangeInRightofuseAssetAndLiabilityDueToModification
250000 USD
cutr Change In Rightofuse Asset And Liability Due To Modification
ChangeInRightofuseAssetAndLiabilityDueToModification
USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
327000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
55000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2209000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4232000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-4588000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6028000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1273000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1423000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
1701000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
2608000 USD
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-5886000 USD
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
2861000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-4559000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
4900000 USD
cutr Increase Decrease In Extended Product Warranty Accrual
IncreaseDecreaseInExtendedProductWarrantyAccrual
-502000 USD
cutr Increase Decrease In Extended Product Warranty Accrual
IncreaseDecreaseInExtendedProductWarrantyAccrual
-927000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-140000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-2398000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
907000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-301000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-21402000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6194000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
774000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
524000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
45000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
19000000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
11450000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
24411000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
8304000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6185000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2667000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
856000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1600000 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
7167000 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
28798000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
2303000 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3340000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
750000 USD
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
513000 USD
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
496000 USD
CY2019Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
17935000 USD
CY2020Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1567000 USD
CY2019Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2016000 USD
CY2020Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
12139000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3173000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
26316000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
26052000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
29394000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
22879000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
27000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
903000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
30665000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
354000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3078000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
10623000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
11734000 USD
cutr Reduction In Board Of Directors Fees In Response To Covid19 Outbreak Percentage
ReductionInBoardOfDirectorsFeesInResponseToCOVID19OutbreakPercentage
0.25 pure
cutr Reduction In Salaries Of Chief Executive Officer President Chief Operating Officer And Some Managers In Response To Covid19 Outbreak Percentage
ReductionInSalariesOfChiefExecutiveOfficerPresidentChiefOperatingOfficerAndSomeManagersInResponseToCovid19OutbreakPercentage
0.25 pure
cutr Reduction In Salaries Of Employees And Furloughs In Response To Covid19 Outbreak Percentage Of Workforce
ReductionInSalariesOfEmployeesAndFurloughsInResponseToCovid19OutbreakPercentageOfWorkforce
0.42 pure
CY2020Q3 cutr Percentage Of Workforce Impacted By Covid19
PercentageOfWorkforceImpactedByCOVID19
0.22 pure
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1500000 USD
cutr Accounts Receivable Provision For Loss Reversal
AccountsReceivableProvisionForLossReversal
1800000 USD
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
300000 USD
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><i><b>Use of Estimates</b></i></p> <p style="margin: 0pt 7.2pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </p> <p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">The preparation of condensed consolidated financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the amounts reported of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the accompanying notes, and the reported amounts of revenue and expenses during the reported periods. Actual results could differ materially from those estimates.  </p> <p style="margin: 0pt 7.2pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </p> <p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">On an ongoing basis, management evaluates its estimates, including those related to warranty obligations, sales commission, allowance for credit losses, and sales allowances, valuation of inventories, fair value of goodwill, useful lives of property and equipment, impairment testing for long-lived-assets, incremental borrowing rates related to the Company’s leases, assumptions regarding variables used in calculating the fair value of the Company's equity awards, expected achievement of performance based vesting criteria, management performance bonuses, fair value of investments, the standalone selling price of the Company's products and services, the period of benefit used to capitalize and amortize contract acquisition costs, variable consideration, contingent liabilities, recoverability of deferred tax assets, residual value of leased equipment, useful life, lease term and effective income tax rates. Management bases estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.</p>
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
1500000 USD
CY2020Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
42439000 USD
CY2020Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1000 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1400000 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
42440000 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
33921000 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
33921000 USD
CY2020Q3 cutr Debt Securities Availableforsale Net Accumulated Gross Unrealized Gain Loss Before Tax
DebtSecuritiesAvailableforsaleNetAccumulatedGrossUnrealizedGainLossBeforeTax
1000 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
13046000 USD
CY2020Q3 cutr Available For Sale Securities Including Restricted Investments
AvailableForSaleSecuritiesIncludingRestrictedInvestments
13046000 USD
CY2020Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
15627000 USD
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
13970000 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
29333000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
33921000 USD
CY2020Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
9121000 USD
CY2019Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
14341000 USD
CY2020Q3 cutr Accrued Sales And Marketing Costs Current
AccruedSalesAndMarketingCostsCurrent
2011000 USD
CY2019Q4 cutr Accrued Sales And Marketing Costs Current
AccruedSalesAndMarketingCostsCurrent
2527000 USD
CY2020Q3 cutr Accrued Inventory Current
AccruedInventoryCurrent
2579000 USD
CY2019Q4 cutr Accrued Inventory Current
AccruedInventoryCurrent
1008000 USD
CY2020Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
2924000 USD
CY2019Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
4401000 USD
CY2020Q3 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
3590000 USD
CY2019Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
3922000 USD
CY2020Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5419000 USD
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
4108000 USD
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
25644000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
30307000 USD
CY2020Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
3155000 USD
CY2019Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
4832000 USD
CY2019Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
4401000 USD
CY2018Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
4668000 USD
CY2020Q3 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
1274000 USD
CY2019Q3 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
1504000 USD
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
3234000 USD
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
5656000 USD
CY2020Q3 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
1505000 USD
CY2019Q3 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
1930000 USD
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
4711000 USD
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
5918000 USD
CY2020Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
2924000 USD
CY2019Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
4406000 USD
CY2020Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
2924000 USD
CY2019Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
4406000 USD
CY2020Q3 us-gaap Extended Product Warranty Accrual Payments
ExtendedProductWarrantyAccrualPayments
200000 USD
us-gaap Extended Product Warranty Accrual Payments
ExtendedProductWarrantyAccrualPayments
500000 USD
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.19
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.59
us-gaap Net Income Loss
NetIncomeLoss
-10260000 USD
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17603000
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14182000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16368000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
761705
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
295699
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
25.52
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
600000
cutr Share Based Compensation Arrangement By Share Based Payment Award Shares Available For Grant In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross
789978
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
46878
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
8.77
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
64959
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
64959
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
38.14
cutr Share Based Compensation Arrangement By Based Payment Restricted Share Available For Grant Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod
431096
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1067782
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
243862
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
26.33
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1982000 USD
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3178000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8057000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7004000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-2628000 USD
us-gaap Net Income Loss
NetIncomeLoss
-26065000 USD
CY2020Q3 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.81 pure
CY2020Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
11800000 USD
CY2020Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
11779000 USD
CY2019Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
13859000 USD
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
14222000 USD
CY2018Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
11855000 USD
CY2020Q3 cutr Contract With Customer Liability Increase Advance Payments Received
ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived
3854000 USD
CY2019Q3 cutr Contract With Customer Liability Increase Advance Payments Received
ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived
3624000 USD
cutr Contract With Customer Liability Increase Advance Payments Received
ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived
9314000 USD
cutr Contract With Customer Liability Increase Advance Payments Received
ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived
13075000 USD
CY2020Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
3809000 USD
CY2019Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
4010000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
11712000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
11457000 USD
CY2020Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
11824000 USD
CY2019Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
13473000 USD
CY2020Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
11824000 USD
CY2019Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
13473000 USD
CY2020Q3 cutr Deferred Revenue Costs Incurred
DeferredRevenueCostsIncurred
1900000 USD
cutr Deferred Revenue Costs Incurred
DeferredRevenueCostsIncurred
5600000 USD
CY2019Q3 cutr Deferred Revenue Costs Incurred
DeferredRevenueCostsIncurred
2300000 USD
cutr Deferred Revenue Costs Incurred
DeferredRevenueCostsIncurred
6500000 USD
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
60000
CY2020Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
12800000 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y5M23D
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14095000
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17603000
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14182000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16368000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14095000
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.13
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.73
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1006000

Files In Submission

Name View Source Status
0001437749-20-023210-index-headers.html Edgar Link pending
0001437749-20-023210-index.html Edgar Link pending
0001437749-20-023210.txt Edgar Link pending
0001437749-20-023210-xbrl.zip Edgar Link pending
cutr-20200930.xsd Edgar Link pending
cutr-20200930_cal.xml Edgar Link unprocessable
cutr-20200930_def.xml Edgar Link unprocessable
cutr-20200930_lab.xml Edgar Link unprocessable
cutr-20200930_pre.xml Edgar Link unprocessable
cutr20200930_10q.htm Edgar Link pending
cutr20200930_10q_htm.xml Edgar Link completed
ex_209725.htm Edgar Link pending
ex_209726.htm Edgar Link pending
ex_209727.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending